We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAGA
1701
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
$1.54M 0.01%
+155,856
New +$1.54M
AHCO icon
1702
AdaptHealth
AHCO
$775M
$1.54M 0.01%
96,055
+71,449
+290% +$1.28M
AM icon
1703
Antero Midstream
AM
$10.5B
$1.53M 0.01%
141,225
+46,868
+50% +$476K
AAQC
1704
DELISTED
Accelerate Acquisition Corp
AAQC
$1.53M 0.01%
156,700
+140,100
+844% +$1.36M
RDUS
1705
DELISTED
Radius Health, Inc.
RDUS
$1.53M 0.01%
172,902
+78,466
+83% +$595K
COLL icon
1706
Collegium Pharmaceutical
COLL
$876M
$1.52M 0.01%
74,897
+45,470
+155% +$859K
ENDP
1707
DELISTED
Endo International plc
ENDP
$1.52M 0.01%
658,874
-34,416
-5% -$101K
TRTN
1708
DELISTED
Triton International Limited
TRTN
$1.52M 0.01%
21,679
-28,602
-57% -$1.85M
SNBR
1709
DELISTED
Sleep Number
SNBR
$1.52M 0.01%
29,961
+17,125
+133% +$1.16M
ROCC
1710
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1.52M 0.01%
43,975
+18,330
+71% +$599K
HI
1711
DELISTED
Hillenbrand
HI
$1.51M 0.01%
34,286
+5,740
+20% +$271K
VCEL icon
1712
Vericel Corp
VCEL
$2.28B
$1.51M 0.01%
39,601
+26,700
+207% +$963K
EHTH icon
1713
eHealth
EHTH
$40.4M
$1.51M 0.01%
121,728
+93,215
+327% +$1.61M
RYAN icon
1714
Ryan Specialty Holdings
RYAN
$10.6B
$1.51M 0.01%
38,868
-12,945
-25% -$492K
MAIN icon
1715
Main Street Capital
MAIN
$5.49B
$1.51M 0.01%
35,310
+30,805
+684% +$1.32M
CHWY icon
1716
Chewy
CHWY
$9.34B
$1.5M 0.01%
36,882
+29,515
+401% +$1.34M
GLNG icon
1717
Golar LNG
GLNG
$5.14B
$1.5M 0.01%
60,703
-11,036
-15% -$182K
XNCR icon
1718
Xencor
XNCR
$1.61B
$1.5M 0.01%
56,281
+44,567
+380% +$1.44M
RVLV icon
1719
Revolve Group
RVLV
$1.7B
$1.5M 0.01%
27,956
-209,265
-88% -$10.6M
KMPR icon
1720
Kemper
KMPR
$1.55B
$1.5M 0.01%
26,535
-4,463
-14% -$248K
CUBI icon
1721
Customers Bancorp
CUBI
$2.8B
$1.5M 0.01%
28,735
-19,505
-40% -$1.19M
HSII
1722
DELISTED
Heidrick & Struggles
HSII
$1.49M 0.01%
37,627
-4,461
-11% -$189K
SHYF
1723
DELISTED
The Shyft Group
SHYF
$1.49M 0.01%
41,233
+12,961
+46% +$551K
EVGRU
1724
DELISTED
Evergreen Corporation Unit
EVGRU
$1.49M 0.01%
+148,850
New +$1.49M
CHS
1725
DELISTED
Chicos FAS, Inc.
CHS
$1.49M 0.01%
309,963
+12,647
+4% +$59.2K

Similar funds

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.